Swiss Lions 100 | 2026 edition
Novartis
Novartis is No. 4 in the Swiss Lions 100 and No. 2 in Life Sciences & Health, with a score of 78.6 out of 100. Headquarters: Basel, canton of Basel-Stadt.
- Swiss Lions score
- 78.6
- Overall rank
- 4of 100
- Life Sciences & Health
- 2of 14
About
Basel-based pharmaceutical company focused on innovative medicines in cardiovascular, immunology, neuroscience and oncology. It was created in 1996 by the merger of Ciba-Geigy and Sandoz.
Why Novartis ranks No. 4
Novartis combines very large global revenue with substantial research and manufacturing in Switzerland, strong recognition and a validated net-zero target, which places it fourth.
Swiss connections
- It was created in Basel in 1996 by the merger of Ciba-Geigy and Sandoz, two companies with roots in the city's 19th-century dye industry.
- Two other companies in this ranking began inside Novartis: the eye care company Alcon and the generics maker Sandoz.
How the score is made
Global scale
CHF 45.8bn revenue.
Swiss value
Swiss made: Partly.
Prominence
Online attention across languages, and worldwide search interest.
Impact
Net-zero target validated. Not a certified B Corp.
Philanthropy
Corporate foundation: Novartis Foundation.
Key figures
- Revenue used in the ranking
- CHF 45.8bnTTM Oct 2026, company
- Revenue
- USD 56.7bnTwelve months to 30 June 2026
- Net profit
- USD 12.8bnAttributable to shareholders
- Dividends paid
- USD 9.1bnTo all shareholders
- Employees worldwide
- 75,267
Employees in Switzerland and dividends paid to Swiss shareholders are not published consistently, so they are not shown.
Profile
- Headquarters
- BaselCanton of Basel-Stadt
- Language region
- German-speaking
- Category
- Life Sciences & Health
- Ownership
- Listed
- Main customers
- Businesses (B2B)
- Chief executive
- Vas NarasimhanSince 2018. American national. Source
- Formed
- 1996Merger of Ciba-Geigy and Sandoz
Nearby in the Swiss Lions 100
Also in Life Sciences & Health
1RocheScore 80.8
3LonzaScore 59.5
4SonovaScore 54.8
5SandozScore 54.5
6StraumannScore 53.5
7FerringScore 48.4
See all 14 brands in Life Sciences & Health.
Sources
- Revenue used in the ranking: stockanalysis.com NOVN (TTM Oct 2026).
- Revenue, net profit, dividends and employees: stockanalysis.com, from company filings.
- Climate target: Science Based Targets initiative dashboard, October 2026. Foundations: Swiss commercial register. B Corp: B Lab directory.
Something out of date?
If a figure is wrong, or Novartis can publish figures for the next edition, tell us. Corrections are recorded with their source.